EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice.

Maria Vitale, Filippo Scialò, Ludovica Coluccino, Anna D'Agostino, Lorella Tripodi, Raffaella Pagliaro, Andrea Bianco, Giuseppe Castaldo, Vincenzo Cerullo, Lucio Pastore

Molecular Therapy · 2026

DOI: 10.1016/j.ymthe.2026.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Maria Vitale und 9 weiteren Autor:innen. Beteiligte Einrichtung: CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy; Kimera s.r.l., Via Gaetano Filangieri 48, 80121 Naples, Italy. Hauptthemen laut MEDLINE: Receptors, LDL, Atherosclerosis, Genetic Vectors, Adenoviridae. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Istruzione dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia (FH) is a genetic disorder caused by mutations in the low-density lipoprotein (LDL) receptor, leading to impaired uptake of LDL and its accumulation in arterial walls and other tissues. This accumulation results in cardiovascular disease and early mortality. Treatments, including statins, ezetimibe, PCSK9 inhibitors, and bempedoic acid, are often insufficient in homozygous FH patients, particularly those with null mutations in the LDL receptor (LDLR). To address this unmet need, we have developed two helper-dependent adenoviral (HD-Ad) vectors for the expression of the murine and human versions of a protein composed of the extracellular portion of the LDLR fused to transferrin. In both cassettes, expression is driven by the murine creatine kinase promoter to obtain high levels of expression restricted to muscle cells, to mitigate host response to the fusion protein. Both human and murine proteins restored LDL uptake in Ldlrf-deficient cells, correcting the phenotype in vitro. A single intramuscular administration of the HD-Ad vector induced the expression of the murine fusion protein, leading to a 12-month improvement in the lipid profile, with a reduction in aortic atherosclerosis in Ldlr-deficient mice. Furthermore, we observed no major systemic toxicity, indicating that the present strategy may represent more effective therapy for FH patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, LDLAtherosclerosisGenetic VectorsAdenoviridaeTransferrinRecombinant Fusion ProteinsAnimalsMiceHumansMice, KnockoutGenetic TherapyDisease Models, AnimalGene ExpressionHyperlipoproteinemia Type IIGene Therapy Agents

Stichwörter der Autor:innen

LDL uptakeLdlr-deficient miceatherosclerosischolesterol metabolismcytotoxicitydyslipidemiafamilial hypercholesterolemiahelper-dependent adenoviral vectorhigh-capacity adenoviral vectorlipid profile

Substanzen

Receptors, LDLTransferrinRecombinant Fusion Proteins

Autor:innen und Institutionen

  • CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy; Kimera s.r.l., Via Gaetano Filangieri 48, 80121 Naples, Italy.
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
  • IRCCS SYNLAB SDN Institute, Via Galileo Ferraris 144, 80143 Naples, Italy.
  • Dipartimento di Scienze Mediche Traslazionali, Università della Campania "L. Vanvitelli", 80131 Naples, Italy; U.O.C. Clinica Pneumologica L. Vanvitelli, A.O. dei Colli, Monaldi Hospital, 80131 Naples, Italy.
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, 80131 Naples, Italy; Drug Research Program…
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, 80131 Naples, Italy. Electronic address: lu…

Förderung

  • Ministero dell'Istruzione dell'Università e della Ricerca

Zitieren

APA

Vitale, M., Scialò, F., Coluccino, L., D'Agostino, A., Tripodi, L., Pagliaro, R., Bianco, A., Castaldo, G., Cerullo, V., & Pastore, L. (2026). Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2026.02.014

Vancouver

Vitale M, Scialò F, Coluccino L, D'Agostino A, Tripodi L, Pagliaro R, et al. Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.02.014

BibTeX
@article{Vitale2026,
  author = {Vitale, Maria and Scialò, Filippo and Coluccino, Ludovica and D'Agostino, Anna and Tripodi, Lorella and Pagliaro, Raffaella and Bianco, Andrea and Castaldo, Giuseppe and Cerullo, Vincenzo and Pastore, Lucio},
  title = {Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice},
  journal = {Molecular Therapy},
  year = {2026},
  doi = {10.1016/j.ymthe.2026.02.014}
}
Kostenlos starten →